Skip to main content

Table 3 Clinical effectiveness

From: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Characteristics

Data

ORR

41.20%

DCR

70.60%

M-PFS (months)

6 (95%CI: 2–9)

6 months PFS rate

64.71%

  1. Data are presented as percentages or means
  2. Abbreviations: ORR The objective response rate, DCR The disease control rate, m-PFS The median progression-free survival
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us